Previous studies have suggested that obestatin plays an important role in obesity and diabetes, however, inconsistency was observed in the data of the relationship between obestatin and obesity/diabetes (Cowan et al., 2016). This evidence concerns the gene GHRL and obesity due to melanocortin 4 receptor deficiency.